| Literature DB >> 26321631 |
Michele Cioffi1, Mireia Vallespinos-Serrano1, Sara M Trabulo2, Pablo Jose Fernandez-Marcos3, Ashley N Firment4, Berta N Vazquez5, Catarina R Vieira1, Francesca Mulero6, Juan A Camara6, Ultan P Cronin7, Manuel Perez8, Joaquim Soriano8, Beatriz G Galvez9, Alvaro Castells-Garcia1, Verena Haage1, Deepak Raj10, Diego Megias8, Stephan Hahn11, Lourdes Serrano5, Anne Moon4, Alexandra Aicher12, Christopher Heeschen13.
Abstract
Conquering obesity has become a major socioeconomic challenge. Here, we show that reduced expression of the miR-25-93-106b cluster, or miR-93 alone, increases fat mass and, subsequently, insulin resistance. Mechanistically, we discovered an intricate interplay between enhanced adipocyte precursor turnover and increased adipogenesis. First, miR-93 controls Tbx3, thereby limiting self-renewal in early adipocyte precursors. Second, miR-93 inhibits the metabolic target Sirt7, which we identified as a major driver of in vivo adipogenesis via induction of differentiation and maturation of early adipocyte precursors. Using mouse parabiosis, obesity in mir-25-93-106b(-/-) mice could be rescued by restoring levels of circulating miRNA and subsequent inhibition of Tbx3 and Sirt7. Downregulation of miR-93 also occurred in obese ob/ob mice, and this phenocopy of mir-25-93-106b(-/-) was partially reversible with injection of miR-93 mimics. Our data establish miR-93 as a negative regulator of adipogenesis and a potential therapeutic option for obesity and the metabolic syndrome.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26321631 DOI: 10.1016/j.celrep.2015.08.006
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423